Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
12.7M
-
Number of holders
-
58
-
Total 13F shares, excl. options
-
4.76M
-
Shares change
-
+64.7K
-
Total reported value, excl. options
-
$140M
-
Value change
-
+$2.01M
-
Number of buys
-
27
-
Number of sells
-
-25
-
Price
-
$29.41
Significant Holders of IRADIMED CORP - Common Stock (IRMD) as of Q2 2021
62 filings reported holding IRMD - IRADIMED CORP - Common Stock as of Q2 2021.
IRADIMED CORP - Common Stock (IRMD) has 58 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.76M shares
of 12.7M outstanding shares and own 37.39% of the company stock.
Largest 10 shareholders include Nine Ten Capital Management LLC (762K shares), RENAISSANCE TECHNOLOGIES LLC (702K shares), Soleus Capital Management, L.P. (497K shares), VANGUARD GROUP INC (490K shares), BlackRock Inc. (405K shares), Russell Investments Group, Ltd. (227K shares), Ranger Investment Management, L.P. (216K shares), RICE HALL JAMES & ASSOCIATES, LLC (212K shares), RK Capital Management, LLC (210K shares), and Mondrian Investment Partners LTD (178K shares).
This table shows the top 58 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.